-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Can AI Be Used in Drug Discovery?

Program: Special-Interest Sessions
Session: AI in Hematology: Where Do You Stand in 2023?
Monday, December 11, 2023, 10:30 AM-12:00 PM

Weida Tong, Ph.D.

Division of Bioinformatics and Biostatistics, National Center for Toxicological Research (USFDA), Jefferson, AR

Disclosures: No relevant conflicts of interest to declare.

See more of: AI in Hematology: Where Do You Stand in 2023?
See more of: Special-Interest Sessions
Previous Presentation | Next Presentation >>